AIM ImmunoTech Inc (AIM)

Nov 04, 2025

AIM ImmunoTech to present phase 2 ovarian cancer study data at SITC - Investing.com

Nov 04, 2025

Nov 04, 2025

AIM ImmunoTech to present phase 2 ovarian cancer study data at SITC By Investing.com - Investing.com South Africa

Nov 04, 2025

Nov 04, 2025

AIM ImmunoTech Announces Late Breaking Abstract from University of Pittsburgh Medical Center Accepted for Presentation at the 40th Annual Society for Immunotherapy of Cancer (SITC) Meeting - The Manila Times

Nov 04, 2025

Nov 04, 2025

AIM ImmunoTech Announces Late Breaking Abstract from - GlobeNewswire

Nov 04, 2025

Nov 04, 2025

Is AIM ImmunoTech Inc. (HXB) stock resilient in recession scenariosMarket Activity Recap & Precise Entry and Exit Recommendations - newser.com

Nov 04, 2025

Nov 04, 2025

Can AIM ImmunoTech Inc. stock expand revenue streamsTrade Risk Assessment & Consistent Income Trade Recommendations - newser.com

Nov 04, 2025

Nov 04, 2025

Is AIM ImmunoTech Inc. stock supported by strong fundamentals2025 Risk Factors & Low Risk High Reward Ideas - newser.com

Nov 04, 2025

Nov 04, 2025

Can AIM ImmunoTech Inc. (HXB) stock hit consensus price targets2025 Fundamental Recap & Fast Gain Swing Trade Alerts - newser.com

Nov 04, 2025

Nov 04, 2025

Is AIM ImmunoTech Inc. stock vulnerable to rate hikesMarket Volume Summary & Smart Investment Allocation Insights - newser.com

Nov 04, 2025

Nov 03, 2025

How forex fluctuations impact AIM ImmunoTech Inc. stockJuly 2025 Update & AI Optimized Trading Strategy Guides - newser.com

Nov 03, 2025

Nov 03, 2025

Why AIM ImmunoTech Inc. stock attracts HNW investorsInsider Selling & Weekly Return Optimization Plans - newser.com

Nov 03, 2025

Nov 03, 2025

How buyback programs support AIM ImmunoTech Inc. (HXB) stockQuarterly Risk Review & Weekly Top Gainers Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

AIM ImmunoTech Announces European Patent Office Grants Patent Covering Ampligen® (Rintatolimod) for Use in the Treatment of the Post-COVID Condition of Fatigue - The Manila Times

Nov 03, 2025

Nov 03, 2025

AIM ImmunoTech Announces European Patent Office Grants - GlobeNewswire

Nov 03, 2025

Nov 03, 2025

AIM ImmunoTech (NYSE American: AIM) gains EU patent for Ampligen in post‑COVID fatigue - Stock Titan

Nov 03, 2025

Nov 03, 2025

What downside risks could hit AIM ImmunoTech Inc. (HXB) stockIndex Update & Low Risk High Reward Ideas - newser.com

Nov 03, 2025

Nov 03, 2025

How AIM ImmunoTech Inc. stock stacks up against competitors2025 Price Action Summary & Safe Entry Trade Reports - newser.com

Nov 03, 2025

Oct 30, 2025

Is AIM ImmunoTech Inc. stock dividend growth reliableNew Guidance & Verified Swing Trading Watchlist - newser.com

Oct 30, 2025